Sorafenib Eugia

Sorafenib Tosilate is an oral medication used for certain types of cancer treatment. It belongs to the kinase inhibitor class, targeting specific proteins to slow cancer cell growth. This EU-sourced version is manufactured by Eugia Pharma. Consult a healthcare provider for suitability.

Sorafenib Tosilate is primarily used to treat advanced kidney cancer, liver cancer, and differentiated thyroid cancer. It works by blocking signals that promote tumor growth and blood vessel formation. Patients often ask, 'what is Sorafenib used for' in these contexts. The medication may also be prescribed for off-label uses under medical supervision.

Common effects of Sorafenib Tosilate include fatigue, skin reactions like rash or redness, and gastrointestinal discomfort such as diarrhea or nausea. Some users report changes in taste or weight loss. These effects vary by individual and are typically monitored during treatment.

Store Sorafenib Tosilate at room temperature away from moisture and heat. Keep it in its original packaging until use. Always handle with care, avoiding contact with skin or eyes. If a dose is missed, follow the prescribed schedule and consult a healthcare provider for guidance.

Sorafenib Tosilate may interact with certain medications, including strong CYP3A4 inhibitors or inducers, blood thinners, and some chemotherapy drugs. Alcohol use should be discussed with a doctor. Grapefruit products may also affect how the medication works. Always inform your healthcare provider about all drugs you are taking.